Atlas Trials

Urine Metabolites in the Diagnosis of Disease

Clinical trial NCT06710067 · RECRUITING

Trial details

NCT number
NCT06710067
Sponsor
Luventix, Inc.
Status
RECRUITING
Study type
OBSERVATIONAL
Colorectal CancerSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Crohn DiseaseCeliac Disease
Start date
2024-10-01
Primary completion
2025-09-01
Enrollment
1250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.